Search

Your search keyword '"Ando, Masaharu"' showing total 50 results

Search Constraints

Start Over You searched for: Author "Ando, Masaharu" Remove constraint Author: "Ando, Masaharu" Database Unpaywall Remove constraint Database: Unpaywall
50 results on '"Ando, Masaharu"'

Search Results

3. Hepatocellular carcinoma recurrence in HCV patients treated with direct-acting antivirals after curative treatment

5. Predictor factor of survival in advanced hepatocellular carcinoma treated with sorafenib ∼a multicenter study∼

7. Risk of secondary osteoporosis due to lobular cholestasis in non‐cirrhotic primary biliary cholangitis

10. Hand-Foot Syndrome and Post-Progression Treatment Are the Good Predictors of Better Survival in Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter Study

14. A target-controlled infusion system with bispectral index monitoring of propofol sedation during endoscopic submucosal dissection

15. Tu1879 The Relations Between Gastroesophageal Reflux Disease and Metabolic Syndrome-Related Diseases in Japanese: A Longitudinal Study

20. Mo1680 Endoscopic Observation Method Using Monochrome Mode Is Useful for Vascular Lesions Compared With Current NBI System in Distant View

22. Prevalence and associated factors with esophageal varices in early primary biliary cirrhosis

23. Peppermint Oil Solution Is Useful as an Antispasmodic Drug for Esophagogastroduodenoscopy, Especially for Elderly Patients

26. Efficacy and cost-effectiveness of consensus interferon monotherapy with high-dose induction for hepatitis C patients with genotype 2

31. Efficacy of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis

32. Clinical features of type 1 autoimmune hepatitis in adolescence and early adulthood

33. Mortality rate of patients with asymptomatic primary biliary cirrhosis diagnosed at age 55 years or older is similar to that of the general population

34. Factors associated with adherence to combination therapy of interferon and ribavirin for patients with chronic hepatitis C: importance of patient's motivation and physician's treatment experience

35. Clinical features of antinuclear antibodies-negative type 1 autoimmune hepatitis

39. A prospective and comparative cohort study on efficacy and drug resistance during long-term lamivudine treatment for various stages of chronic hepatitis B and cirrhosis

41. S1942 A Randomized Trial of Standard vs. Dose-Escalation Dosing of Ribavirin in Combination Therapy for Chronic Hepatitis C Patients with Genotype 1 and High Viral Load

44. Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C

45. Risk factors for hepatocellular carcinoma in Hepatitis C patients with sustained virologic response to interferon therapy

46. Base-Line level of tumor markers (AFP and DCP) and their normalization by treatment contribute to the prognosis of patients with hepatocellular carcinomas (HCC)

47. Des-gamma-carboxy prothrombin is useful in the diagnosis of patients with hepatocellular carcinomas, but depend on tumor size

48. Predictive factors for dose modification and premature discontinuation of interferon plus ribavirin for adverse effects in Japanese patients with chronic hepatitis C

49. Peripheral Arterial Coil Embolization for Hepatic Arteriovenous Malformation in Osler-Weber-Rendu Disease; Useful for Controlling High Output Heart Failure, but Harmful to the Liver.

Catalog

Books, media, physical & digital resources